reports
SAB Biotherapeutics Appoints Jay Skyler, MD, to the Board of Directors
SAB Biotherapeutics Appoints Jay Skyler, MD, to the Board of Directors MIAMI, May 06, 2024 (GLOBE NEWSWIRE) -- SAB Biotherapeutics (Nasdaq: SABS) (the “Company” or “SAB”), a clinical-stage biopharmaceutical company with a novel immunotherapy platform developing a human anti-thymocyte immunoglobulin (hIgG) for delaying the onset or progression of type 1 diabetes (T1D), today announced that Jay Skyler, MD, MACP, FRCP has been appointed to the company’s Board of Directors. “Dr. Skyler’s appointment to our Board of Directors is a major milestone for SAB,” said Samuel J. Reich, SAB’s chairman...
Flow Capital Announces Repayment of USD 4.5 Million Investment
Flow Capital Announces Repayment of USD 4.5 Million Investment TORONTO, May 06, 2024 (GLOBE NEWSWIRE) -- Flow Capital Corp. (TSXV: FW) ("Flow Capital"), a leading provider of flexible growth capital solutions, is pleased to announce the full repayment of a USD 4.5 million investment in an environmental solutions provider. Flow Capital continues to focus on providing flexible growth financing solutions to small and mid-cap high-growth companies across multiple sectors. With the help of our capital, companies are better able to execute their growth plans, scale their operations more aggres...
N2OFF: Save Foods to Target California’s Hemp Market
N2OFF: Save Foods to Target California’s Hemp Market More than half of US hemp flower grown in California recently received Pre-Harvest Regulatory Approval in California allowing Save Foods to treat hemp Neve Yarak, Israel, May 06, 2024 (GLOBE NEWSWIRE) -- \ (NASDAQ: NITO) (FSE:80W) (“N2OFF” or the “Company”), a pioneer agri-food tech company offering sustainable solutions for agriculture and plant-based food, announced today that its subsidiary Save Foods Ltd. (“Save Foods”) is set to target the hemp flower market in California. The Company recently announced that the California Depar...
Skyward Specialty Announces Secondary Offering of Its Common Stock
Skyward Specialty Announces Secondary Offering of Its Common Stock HOUSTON, May 06, 2024 (GLOBE NEWSWIRE) -- Skyward Specialty Insurance Group, Inc. (NASDAQ: SKWD) (“Skyward Specialty” or the “Company”) a leader in the specialty property and casualty (“P&C”) market, announced that The Westaim Corporation (“Westaim”), through its wholly-owned subsidiary, Westaim HIIG GP Inc. (the “Selling Stockholder”) is offering 4,400,000 shares of the Company’s common stock in an underwritten secondary public offering. In connection with the offering, the Selling Stockholder has also granted the underwr...
Clariane : Modalités de mise à disposition et de consultation des info...
PARIS--(BUSINESS WIRE)-- Regulatory News: Clariane (CLARIA.PA – ISIN FR0010386334) (Paris:CLARI) informe ses actionnaires qu’une Assemblée générale mixte (l’« Assemblée générale ») de la Société se tiendra le lundi 10 juin 2024 à 10 heures à la salle Apostrophe, située 83 avenue Marceau, 750016 Paris. L’avis préalable de réunion comportant l’ordre du jour, le texte des projets de résolutions présentés par le Conseil d’administration ainsi que les modalités de participation et de vote à l’Assemblée générale a été publié au Bulletin des Annonces Légales Obligatoires n° 55 du 6 mai 2024. Le...
ALLETE Enters Agreement to be Acquired by a Partnership Led by Canada ...
DULUTH, Minn.--(BUSINESS WIRE)-- ALLETE, Inc. (NYSE: ALE) and a partnership led by Canada Pension Plan Investment Board (“CPP Investments”) and Global Infrastructure Partners (“GIP”), (the “partnership”), today jointly announced that they have entered into a definitive agreement under which the partnership will acquire ALLETE for $67.00 per share in cash, or $6.2 billion including the assumption of debt. ALLETE is a leading energy company and provider of safe, reliable, and competitively priced energy with a national footprint. Together, ALLETE and its family of companies, which includes reg...
Stellantis Pro One Achieves No. 1 Spot in Middle East & Africa Region ...
Stellantis Pro One Achieves No. 1 Spot in Middle East & Africa Region and Strengthens Commercial Vehicle Leadership in Europe and South America Stellantis Pro One Achieves No. 1 Spot in Middle East & Africa Region and Strengthens Commercial Vehicle Leadership in Europe and South America Achieves No. 1 spot with a record 26% market share in Middle East & Africa, led by strong performance in Algeria with the FIAT Professional brand Confirms market leadership in Europe 30 and South AmericaNorth America plays a key role in Pro One success; Ram announces new professional commercial vehicle divi...
AMG Reports Financial and Operating Results for the First Quarter of 2...
AMG Reports Financial and Operating Results for the First Quarter of 2024 Company reports EPS of $4.14, Economic EPS of $5.37 in first quarter Net Income (controlling interest) of $150 million, Economic Net Income (controlling interest) of $187 millionEconomic Earnings per share increased 28% year-over-year, reflecting strong business momentum and the positive impact of our capital allocation strategyIssued $450 million of 40-year junior hybrid debt and repurchased approximately $150 million in common stock WEST PALM BEACH, Fla., May 06, 2024 (GLOBE NEWSWIRE) -- AMG, a leading partner t...
Sanergy Group Limited: 1 director
A director at Sanergy Group Limited sold 78,000,000 shares at 2.580HKD and the significance rating of the trade was 70/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two year...
Anton Oilfield Services Group: 1 director
A director at Anton Oilfield Services Group sold 1,125,000 shares at 0.426HKD and the significance rating of the trade was 62/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last t...
Omega Therapeutics Reports First Quarter 2024 Financial Results and Hi...
Omega Therapeutics Reports First Quarter 2024 Financial Results and Highlights Recent Company Progress Advanced MYCHELANGELO™ I trial dose escalation to Cohort 5; Presentation of additional monotherapy data and planned expansion into Phase 2 settings expected in mid-2024Presented new preclinical data demonstrating potential of a MYC-targeting epigenomic controller in NSCLC at AACR 2024Company to present new preclinical data demonstrating durable epigenomic upregulation and other OMEGA platform capabilities at ASGCT 2024 CAMBRIDGE, Mass., May 06, 2024 (GLOBE NEWSWIRE) -- O...
Neumora Therapeutics to Participate in Upcoming Conferences in May
Neumora Therapeutics to Participate in Upcoming Conferences in May WATERTOWN, Mass., May 06, 2024 (GLOBE NEWSWIRE) -- Neumora Therapeutics, Inc. (Nasdaq: NMRA), a clinical-stage biopharmaceutical company with a therapeutics pipeline consisting of seven clinical and pre-clinical brain disease programs, today announced that the Company will participate in two investor conferences in May: BofA Securities Healthcare Conference 2024: Members of management will participate in a fireside chat on Tuesday, May 14, 2024, at 1:00 PM ET (10:00 AM PT) in Las Vegas, NV.2024 RBC Capital Markets Global ...
Agios to Present at the BofA Securities 2024 Health Care Conference on...
Agios to Present at the BofA Securities 2024 Health Care Conference on May 16, 2024 CAMBRIDGE, Mass., May 06, 2024 (GLOBE NEWSWIRE) -- Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a leader in cellular metabolism and PK activation pioneering therapies for rare diseases, today announced that the company is scheduled to present at the BofA Securities 2024 Health Care Conference on Thursday, May 16, 2024, at 11:40 a.m. ET. A live webcast of the presentation can be accessed under "Events & Presentations" in the Investors section of the company's website at . A replay of the webcast will be arc...
Cara Therapeutics to Announce First Quarter 2024 Financial Results on ...
Cara Therapeutics to Announce First Quarter 2024 Financial Results on May 13, 2024 STAMFORD, Conn., May 06, 2024 (GLOBE NEWSWIRE) -- Cara Therapeutics, Inc. (Nasdaq: CARA), a development-stage biopharmaceutical company leading a new treatment paradigm to improve the lives of patients suffering from pruritus, today announced the Company will report first quarter 2024 financial results on Monday, May 13, 2024, after the U.S. markets close. The press release will be available under “Press Releases” in the Investors section of the Company’s website at . About Cara Therapeutics Cara Therapeu...
BioCryst Reports First Quarter 2024 Financial Results and Provides Bus...
BioCryst Reports First Quarter 2024 Financial Results and Provides Business Update —Q1 2024 ORLADEYO net revenue grows 30 percent y-o-y to $88.9 million— —Full-year 2024 ORLADEYO revenue guidance adjusted to $390-$400 million (top end of prior guidance range) — —Pipeline programs, including BCX17725 for Netherton syndrome and avoralstat for DME, advancing on schedule into clinical trials— RESEARCH TRIANGLE PARK, N.C., May 06, 2024 (GLOBE NEWSWIRE) -- (Nasdaq:BCRX) today reported financial results for the first quarter ended March 31, 2024, and provided a corporate update. “We are off...
Brookfield Asset Management and Castlelake to Enter into Strategic Par...
Brookfield Asset Management and Castlelake to Enter into Strategic Partnership Brookfield to acquire 51% interest in Castlelake’s fee-related earnings and invest in the firm’s funds and strategies, total capital amounting to $1.5B BROOKFIELD NEWS, May 06, 2024 (GLOBE NEWSWIRE) -- Brookfield Asset Management (NYSE: BAM, TSX: BAM) (“Brookfield”) and Castlelake L.P. (“Castlelake”), an alternatives asset manager specializing in asset-based private credit including aviation and specialty finance, today announced that they have entered into an agreement whereby Brookfield will acquire a 51% s...
Can-Fite Received Notice of Allowance from the European Patent Office ...
PETACH TIKVA, Israel--(BUSINESS WIRE)-- . (NYSE American: CANF) (TASE:CANF), a biotechnology company advancing a pipeline of proprietary small molecule drugs that address oncological and inflammatory diseases, today announced it received a Notice of Allowance from the European Patent Office for its patent application titled “An A3 Adenosine Receptor Ligands For Use in Treatment of a Sexual Dysfunction”. This invention addresses the use of the CF602 drug candidate as an oral or topical drug for patients such as diabetics, who suffer from erectile dysfunction, and cannot use the current drugs on...
Apellis Pharmaceuticals to Host a Fireside Chat at the Bank of America...
Apellis Pharmaceuticals to Host a Fireside Chat at the Bank of America Securities Healthcare Conference WALTHAM, Mass., May 06, 2024 (GLOBE NEWSWIRE) -- Apellis Pharmaceuticals, Inc. (Nasdaq: APLS) today announced that the company will host a fireside chat at the Bank of America Securities Healthcare Conference on Tuesday, May 14, 2024, at 8:00 a.m. PT. The live conference webcast will be posted on the “Events and Presentations” page of the “Investors and Media” section of the company’s . A replay of the webcast will be available for approximately 90 days following the event. About Apel...
Voyager Therapeutics Announces First Quarter 2024 Conference Call and ...
Voyager Therapeutics Announces First Quarter 2024 Conference Call and Webcast LEXINGTON, Mass., May 06, 2024 (GLOBE NEWSWIRE) -- Voyager Therapeutics, Inc. (Nasdaq: VYGR), a biotechnology company dedicated to advancing neurogenetic medicines, today announced it will report first quarter 2024 financial and operating results after market close on Monday, May 13, 2024. Subsequently, the Company will host a conference call and webcast at 4:30 p.m. ET to review its financial and operating results. To participate via telephone and join the call live, please register in advance here: . Upon reg...
Join Mobilicom’s Exclusive Live Investor Webinar and Q&A Session on Ma...
Join Mobilicom’s Exclusive Live Investor Webinar and Q&A Session on May 9 SHOHAM, Israel, May 06, 2024 (GLOBE NEWSWIRE) -- Mobilicom Limited (Nasdaq: MOB), a provider of cybersecurity and robust solutions for drones and robotics, is pleased to invite investors to a webinar on May 9, 2024, at 4:15 p.m. ET. The exclusive event, hosted by RedChip Companies, will feature Mobilicom Founder and CEO Oren Elkayam, who will share insight into the Company’s recent successes and near-term growth initiatives. A live Q&A session with Elkayam will follow the presentation. To register for ...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.